CNW/ - Pfizer Canada is pleased to announce that ABRYSVO, its vaccine for the prevention of Respiratory Syncytial Virus (RSV) ...

With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that ...

Historically, RSV has been associated with infants, but they are not the only group that can be affected by serious RSV ...

Sanofi has dropped its respiratory syncytial virus (RSV) vaccine for toddlers after the candidate underperformed in a phase 3 ...

Pfizer's Q3 results are set to reveal mixed trends across non-oncology drugs, with strong Eliquis and Paxlovid sales offset ...

Key opinion leaders previously interviewed by GlobalData noted the need for more data on current RSV vaccines and their use ...

Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...

ATLANTA -- Maternal respiratory syncytial virus (RSV) vaccination during pregnancy and infant RSV immunization -- either ...

Deflation generally occurs when demand falls and supply increases. Supply increases when production costs drop.

Heading into winter respiratory virus season, Kaiser Permanente is advising expecting moms to get vaccinated against RSV to protect their newborns.

Over the past decade, pharmaceutical maker Pfizer ( PFE -0.53%) has severely lagged the market. Dividends reinvested aside, ...